Crispr Therapeutics Ag · NASDAQ:CRSP
Kulkarni Samarth sold 4,098 Crispr Therapeutics Ag shares (Form 4)
Traded Oct 13 to Oct 14, 2026 · Filed Oct 15, 2026
From Oct 13 to Oct 14, 2026, Kulkarni Samarth (Director, Chief Executive Officer) sold 4,098 Crispr Therapeutics Ag shares at US$49.26 for US$202K, leaving 259,736 shares. Filed Oct 15, 2026 (Form 4).
- Sold
- 4,098 shares
- Price
- US$49.26
- Value
- US$202K
- Holding after
- 259,736 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Common Shares | Option exercise | 8,333 | 263,834 | Direct | |
| Oct 14, 2026 | Common Shares | Sale | 4,098 | US$49.26 | 259,736 | Direct |
Source
Download original · View original at SEC